app. · pdf fileiçî~ëí~íáå qm pnb um ......

5
!"#$%&'( Tzu Chi Med J 2006 18 (Suppl 1) ! NR !"#$%&'()* !"#$% !"#$%& !"#$%&'()*+,-. P TMT !"#$%&'()*+,-. !" !"#$%&'()*+,-.)*+/0123456789:,OMMN^qmfff!"#$%& !"# R !"#$%&' emp molsb=fqJqfjf=OO iai !"#$ J !"#$%& !" iai !" NMM=ãÖLÇi !"#$%&'!()*+,-./01234 iai QM=ãÖLÇi !"#$%&'(N iai PM=ãÖLÇi !"#$%&'()*+,PMBOMMQ ^qmfff !"#$%&'()*+,-./0123456789:;<=.>?@ABCDEFGH.?I%&J !" iai !"#$%&'( ëí~íáå ! O !"#$%&'()*+,-./012345 !"#$%&'()*+,-./01#23456E!"#$% NMM=ãÖLÇi F!"# O !"#$%&'()*+,-./0iaiTM=ãÖLÇi!"#$%&'()*+,-./,01 =2006; 18(Suppl 1):15-19 !!"#$!%&' !"#$%&'()*+,-./01 !"#$%&'"()$%&'"*+&' !"#$%&'()*+,-./01 !"#$%&'()*+,-"./'01 !"EgçëäáåF!"#$%&'ENF NVOO !"#$%&'()*+,-./01 !"#$NSBJOPB !"NVSQ ! UNB !"#$ ROB !"#$ NOB !"#$ OB !"# NRB !" !"#$%&'RO!"#$%&NO !"#$%&' NR !"#$%&' O !"#$%&'()*+,-./012 USB !"#$%&'(!)*+,-./0 OMMONN!"#$%&'()*+ !"#$%&'()*+,-./0123 !"#$%&'()*+,-./012 !"#$%&'()*+ !"# !"#$%&'( VJNO !"#$ !"#$%&'()*+,-./012 !"#$%&'E! iaiF! !"#E! eaiF!"#$%& !"#$%&'(eai iai !"#$iai !"#$%&'()*

Upload: doduong

Post on 14-Mar-2018

215 views

Category:

Documents


3 download

TRANSCRIPT

Page 1: app.  · PDF fileiçî~ëí~íáå QM PNB UM ... hypertensive patients randomised to pravastatin vs usual ... Cir-culation 2004; 110:227-239. 9. Haffner SM,

�� !"#$%&'(

Tzu Chi Med J 2006 � 18 (Suppl 1) �� ! NR

�� !"#$%&'()*

�� �� ��

�� !"#$% �� !"#$%&

�� !"#$%&'()*+,-. P� TMT� �� !"#$%&'()*+,-. �� !"

��

�� !"#$%&'()*+,-.)*+/0123456789:,OMMN�^qmfff�� !"#$%&

�� !"# R�� !"#$%&'emp�molsb=fqJqfjf=OO�� iai�� !"#$ J�� !"#$%&

�� !"iai�� !"NMM=ãÖLÇi�� !"#$%&'!()*+,-./01234iai�QM=ãÖLÇi��

�� !"#$%&'(N��iai�� PM=ãÖLÇi�� !"#$%&'()*+,PMB�� �OMMQ�^qmfff

�� !"#$%&'()*+,-./0123456789:;<=.>?@ABCDEFGH.?I%&J

�� !" iai�� !"#$%&'( ëí~íáå�� ! O�� !"#$%&'()*+,-./012345

�� !"#$%&'()*+,-./01#23456E�� !"#$%NMM=ãÖLÇi��F�� !"#O��

�� !"#$%&'()*+,-./0iai�� TM=ãÖLÇi�� !"#$%&'()*+,-./,01�

�� =2006; 18(Suppl 1):15-19

�� !�� !"#$!%&'

� �

�� !"#$%&'()*+,-./01

�� !"#$%&'"()$%&'"*+&'

�� !"#$%�&'()*+,-.�/01

�� !"#$%&'()*+,-"./'01

�� !"EgçëäáåF�� !"#$%&'E�NF��

NVOO�� !"#$%&'()*+,-./01

�� !"#$NSBJOPB�� !"NVSQ�� !

�UNB�� !"#$ROB�� !"#$NOB�

�� !"#$ OB�� !"# NRB�� !"

�� !"#$%&'RO�� !"#$%&NO�

�� !"#$%&' NR�� !"#$%&' O

�� !"#$%&'()*+,-./012

USB�� !"#$%&'(!)*+,-./0

�� OMMO�NN�� !"�#$%&'()*+

�� !"#$%&'()*+,-./0123

�� !"#$%&'()*+,-.�/012

�� !"#$%&'()*+

�� !"#

�� !"#$%&'(VJNO�� !"#$

�� !"#$%&'()*+,-./012

�� !"�#$%&'E�� ! iaiF�� !

�� !"#E�� ! eaiF�� !"#$%&

�� !"#$%�&'(eai�� iai��

�� !"#$iai�� !"#$%&'()*

Page 2: app.  · PDF fileiçî~ëí~íáå QM PNB UM ... hypertensive patients randomised to pravastatin vs usual ... Cir-culation 2004; 110:227-239. 9. Haffner SM,

�� �� ��

Tzu Chi Med J 2006 � 18 (Suppl 1)NS �� !

�� !"#$%&'()*+,-./0123

�� !"#$%PIMRR�� !"#$%&'()

�� !"EråáíÉÇ= háåÖÇçã= mêçëéÉÅíáîÉ= aá~ÄÉíÉë

píìÇó�� !"rhmapF�� ! PPR�� NM��

�� !"#$%&'()*+,-./0123

�� !"#$%&'iai�eai�^N`�� !

�� xNz�� !"#$%&'()*+,-.

��

�� !"#$%&'()*+

�� !"#$%&'()*+,-.'/

��iai�� eai�� !"#$%&'N��

� O�� !"#$%&'()*+,-.

�� !"#$

�� N�� !"#$%&'()*+,-.

�� !"#$ % �� !"#$%!&'(

�� !"#$%&'()*+%,-.��/0

�� !"#$%&'()*+,-./0123

�� !"#$%&'( O�� !"#$%&'

�� !"#$ �� !"#$%!&'()*

�� !"#$%&'()*+,-./012�

�� !"#$%&'()*+,-./01*!

�� !"#$%&'()*+,"-. ��

�� !"#$%&'()*+,-./012

�� !"#$%&'()*

�� ! O�� !"#$%&'()*+,

�� OMMJQMM=ãÖLÇi�� !"#$ QMM=ãÖLÇi �

�� !"#$%&'()'*+,-./012

�� !"#$%&'()*+,-./01

iai��

�� !"#$%&'()*+,-./01

�� !"#$%& N�� !"#$%&'()

�� !"# O �� !"#$%&'()*+

iai�� !"#$%&'()*+,-./ 0

� iai �� NVM=ãÖLÇi�� !"#$%&'()

�� !"#$%

eai��

eai�� !"#$%&'(#)*+,�-

�� !"#$% �� !"#$eai�� !

�� !"#eai�� !"#$%&'() *

�� !"#$%!eai�� !"#$%&'(

�� !"#$%&'()*+,-./01

�� !"#$%

� NVVU�� e~ÑÑåÉê�� !"b~ëí=~åÇ=tÉëí

�� !"#$%&'()*+,-./0%&,

�� !"#$�%&'()*+,-./!0

�� !xVz�� �OMMN�� !"#$%&'

�� !"#$%&'()E�� !^qmfffF��

�� !"#$xOz�� !"#$%&'()*+

�� !"#$%& iai �� NMM==ãÖLÇi�� !

�� !" R�� !"xPJTz�� !"#$ emp

� molsb=fqJqfjf=OO�� iai�� !"#$ J

�� !"#$%iai�� !"#$%�&'(

�� !"#$%&'iai�QM=ãÖLÇi�� !"

�� !"#$% N��iai�� PM=ãÖLÇi��

�� !"#$%&'()*PMB�� �OMMQ�

^qmfff�� !"#$%&'()*+,-./0

� NK �� gçëäáå�� !"#�� $%&'(#)*+,=E�� F

�� L �� NUVUJNVOO NVOOJNVQV NVRMJNVSQ NVSRJNVTV

�� !" QQKT QKR NKM NKO�� ! OOKS SPKS TTKM TRKS

�� VKV PSKN RPKP RQKR�� PKU RKN VKM TKM� QKV NMKN NOKR NNKN�� QKO NMKN NKP MKV

�� NNKO VKQ RKU QKP�� QKV OKO MKP MKM

�� PKO VKO NMKN NOKM

��

��

��

��

Page 3: app.  · PDF fileiçî~ëí~íáå QM PNB UM ... hypertensive patients randomised to pravastatin vs usual ... Cir-culation 2004; 110:227-239. 9. Haffner SM,

�� !"#$%&'(

Tzu Chi Med J 2006 � 18 (Suppl 1) �� ! NT

�� !"#$%&'()*+=�� !"#$%

�� !"#$%�� !"#$%� !"&'

�� !"#$%&'()*+,-./E�OF=xUz�

�� ^qmfff�� !"#$%&'()*+,-

�� OMB�� !"#$%&'()*+,-.

��ENF�� !"EOF�� !"#$%&'(EPF�

�� !"#$%&'()*+,EQF�� !"#

�� !"#$%&'()*+ ,

^qmfff�� !"#$%&'()*+,-.

�� !"#$%&'!()!*+,!-eai�

�� !"#$%&'()

NK=�� QR�� !"#$RR�� !"#$%&

�� !"#$%&'(

OK=�� !"#$%&'()*+,- RR��

�� SR�� !"#$%&'

PK=�� !"#$�%&

QK=�� !� ≥NQMLVM=ããeÖ�� !"#$%&

�� !

RK=eaiYQM=ãÖLÇi�� eai≥SM=ãÖLÇi�� !"

�� !"#$%&'()*+,-.

�� O�� !"#$%&'()*+,-

�� !"#$%&'($)*+,-./01

�� !"#$%&'()E�� !"#$% NMM

ãÖLÇi��F�� !"# O�� !"#$%&'

�� !"#$%&'( iai�� TM=ãÖLÇi �

�� !"#$%&'()*+,-.+/0

�� !"#

�� !"#$%"#&'()*+,

EíÜÉê~éÉìíáÅ=äáÑÉëíóäÉ=ÅÜ~åÖÉ�� qi`F�� !"#

�� !"#$%&

��OMMQ�^qmfff�� !"#$%&'()

�� !"#$%&'iai��TM=ãÖLÇiE�� !

�� ! iai �� NMM=ãÖLÇiF�� !"#$%&

�� !"#$%&'()*+,-.,/012

�� !"#$%&'()*+,-./01�2

�� !"#$%&'(!" RRB�NRB��

�� !"#$%&'( !�PMB�� !"#

�� !"#E�� !"TB��F�� !"#$

�E�� !" NMB��F�� !"#$%&'(

�� !"E�� !"NMBJNRBF�� !"#$%

�� !OMM�� !"#$%&'(ORM�� !

�� !"#$%&'()*+, -./0 PJQ

�� !"#$%&'()NMJNR�� !"#$%

�� !�"!�#��$%&'(�)*+,�

�� !"#$%&'()*+,-./ L��

�� ! O�� !"#$%&'()*+),

�� !�"#�$%�&'�()�*+�,-

�� !

�� !

^qmfff�� !"#$%&'()*+,-.

�� !"#$%&'(iai��TM=ãÖLÇi��

�� !"#$%&' iai �� NMM=ãÖLÇi��

�� !"#$%&'() iai�� N=ãÖLÇi �

�� !"#$%&'()*+,-. NB�

�� !"ëí~íáå�� !"#$%&'()*

�� !"#$%&'ëí~íáå�� !"#$%%&

�� !"#$%&'()*+,-#./ ^qmfff

�OMMQ�� !"#ëí~íáå�� !"#$%&'(

��iai�� !"#$%&'()*+,- !

� OK �� !"#$%&'()*+,-./0123)4567

� � �� !"#$%&' � � iai�� ! �� !"#$

�� !"#�� GG �� OMB �� !"#$ G YTM=ãÖLÇi iai≥NMM=ãÖLÇi�� OMB �� !" YNMM=ãÖLÇi iai≥NMM=ãÖLÇi

EçéíáçåW=YTM=ãÖLÇiF�� ! ≥O � NMBJOMB �� !"#$ YNPM=ãÖLÇi iai≥NPM=ãÖLÇi

EçéíáçåW=YNMM=ãÖLÇiF�� ! ≥O � �� NMB �� !"# YNPM=ãÖLÇi iai≥NSM=ãÖLÇi�� ! MJN � �� !" YNSM=ãÖLÇi iai≥NVM=ãÖLÇi

G�� !"#$%&'()*+,-./01OMB�� !"#$%&'()*+,!-./012345678ENF�� !"#EOF�� !"#$%&'()EPF�� !"#$%&'()*+,-.EQF�� !"#$%&'GG�� !"#$%&'()*+,-.�� !"#��$%&!"'()

Page 4: app.  · PDF fileiçî~ëí~íáå QM PNB UM ... hypertensive patients randomised to pravastatin vs usual ... Cir-culation 2004; 110:227-239. 9. Haffner SM,

�� �� ��

Tzu Chi Med J 2006 � 18 (Suppl 1)NU �� !

�� !"#$%&'()*+,-PMBJQMB��

�� !"#$%&ëí~íáå�� !"#$%&'(

�� !"#$%&PMBJQMBE�PF�� !"#$

�� !"#$iai�� !"#$%&'()*

�� !"#$ SB=iai �

pí~íáå�� !"#$%&'()*+,ejdJ

`ç^�� �� !"#$%&�'(iai��

�� !siai�iai�� !"#$%iai��

�� !"#$%&'()* eai� pí~íáå��

�� NUBJRRB� iai� TBJPMB�� !"#$

�� RBJNRB�eai�

��ëí~íáå�� !"#$%&'()'*+'

�� !"#$%&'"()"*+,-./01

�� !��"#$ OJP�� !"#$%&'(

� ëí~íáå�� !"#$%&'()*+ ,-.

�� !"#$% ÉêóíÜêçãóÅáå � áíê~Åçå~òçäÉ�

ÅóÅäçëéçêáåÉ�ÖÉãÑáÄêçòáä� ÑÉåçÑáÄê~íÉ�� !"#

�� ÅóíçÅÜêçãÉmP^Q��äçî~ëí~íáå�ëáãî~ëí~íáå�

~íçêî~ëí~íáå � ëí~íáå�� !"#$% ÅóíçÅÜêçãÉ=mJ

QRM�� !"#$%&'()*+, ëí~íáå��

�� !"#$%&'()*+,-./0123

éê~î~ëí~íáå�� !"#$`vm�� !"#$%

�� !"#$xNMJNOz�� !"#eai�� N

ãÖLÇi�� !"#$%&'()OB�� !"#

� ~íçêî~ëí~íáå=�� !eai�� !"#$%&'

�� ~íçêî~ëí~íáå��eai�� !"xNPJNRz��

�� !"#$%& eai�� !"#$%&'

��

�� !ëí~íáå�� !"#$%&'()*+

�� !"#$%&'()*+,-./&012

�� !"#$%&'()*+,-./012�

�� !"#$%&'ëí~íáå��ÑáÄêáÅ=~ÅáÇ�� !

�� !"#$%&'()*+,-./0123

�� !"# ÉòÉíáãáÇÉ�� !"#$%&'()

�� !"#$%&'()*+,-./0��

�� !"#$%�&'()*+,-`vm��

�� !"#$%&'()ëí~íáå=�ÉòÉíáãáÇÉ��

�� !"#$%&'( ~íçêî~ëí~íáå= NM= ãÖ ��

ÉòÉíáãáÇÉNM=ãÖ��iai�� !"# ~íçêî~ëí~íáå=UM

ãÖ=ENM=ãÖ=H=NM=ãÖ=Z=UM=ãÖFxNSz�� !"#$%&

�� !

�� ^qmfff�� !"#$%&'EOMMJRMM

ãÖLÇiF�� !" iai�� !"#$%&'(

åçåJeaiE�� !" eaiF�� !"#$� iai

�� !"PM�� !"#$%&'(#)*+,

�� E≥RMM=ãÖLÇiF�� !"#$%&'()*�

�� !"#$%&'()*+,-./01 2

iai�� !"#$%&' ÑáÄêáÅ=~ÅáÇ�� !"#

��

�� !"#$

�� !"#$OMMP�� !"#$%&'(

�� !"#$OMM=ãÖLÇi��E�� !OMM=ãÖLÇi

��F�iai�� !"#NMM=ãÖLÇi�� eai�

�� !"#$%QM=ãÖLÇi��E�� !PR=ãÖLÇi

��F=�� ! RM=ãÖLÇi��E�� ! QR=ãÖLÇi�

�F�� !"#$%&'()*+ NRM=ãÖLÇi ��

E�� ! NRM=ãÖLÇi ��F=E� QF�

�� !"#$%&'()*+,-./01

�� !"#iai��NMM=ãÖLÇi�� !"#$%

�� !"�#$%iai��NPM=ãÖLÇi�� iai

� NMMJNPM=ãÖLÇi�� !"#$%&'()*+

�� !"#$%&'()*+,-./0

rhmap�� !"#$%&'()*+,- OMMJ

QMM=ãÖLÇi�� !"#$%iai�� !"#$%

� PK �� ëí~íáå�� iai �� PMBJQMB�� !"

� � �� !=E=ãÖLÇiF iai�� ! �� !E=ãÖLÇiFG

içî~ëí~íáå QM PNB UMmê~î~ëí~íáå QM PQB UMpáãî~ëí~íáå OMJQM PRBJQNB UMcäìî~ëí~íáå QMJUM ORBJPRB UM^íçêî~ëí~íáå NM PVB UMoçëìî~ëí~íáå RJNM PVBJQRB QM

G�� !"#$%&'()*+"#%,-./ SBiai

��

Page 5: app.  · PDF fileiçî~ëí~íáå QM PNB UM ... hypertensive patients randomised to pravastatin vs usual ... Cir-culation 2004; 110:227-239. 9. Haffner SM,

�� !"#$%&'(

Tzu Chi Med J 2006 � 18 (Suppl 1) �� ! NV

� QK �� !"#$%&'()*+,-EOMMP �F

�� !"#

�� ! YOMM=ãÖLÇi�� !" YNMM=ãÖLÇi�� !"E�F [ QM=ãÖLÇi�� !"E�F [ RM=ãÖLÇi�� !" YNRM=ãÖLÇi

�� !eai�� !"#$%&'()*+,-

�� !"#$%≥QMM=ãÖLÇi�� !"#$%&

�� !"#$%&'()*+,-./012�

�� !"#$%&'()^qmfff�� !

� �

�� !"#$%&'()*+,-./01

�� !"#$%&'()*+,-.$/012

�� !"N�� LNMM�� !"#$%&OB��

�� !"#$%&'()*+,"-./(01

�NM�� LNMM�� !"#$%&'()*+,-

�NKO�� !"#$%&'()*+,-(./0

�� !"#$%&'()*+,(-./01

�� !"# $%�&'()*+,-./0

�� !"#$%�&'()*+,-#./01

�� !"

�� !

1. Turner RC, Millns H, Neil HA, et al: Risk factors for coro-nary artery disease in non-insulin dependent diabetesmellitus: United Kingdom Prospective Diabetes Study(UKPDS: 23). BMJ 1998; 316:823-828.

2. Expert Panel on Detection, Evaluation, and Treatmentof High Blood Cholesterol in Adults: Executive Summaryof The Third Report of The National Cholesterol Educa-tion Program (NCEP) Expert Panel on Detection,Evaluation, And Treatment of High Blood CholesterolIn Adults (Adult Treatment Panel III). JAMA 2001; 285:2486-2497.

3. Jones PH, Davidson MH, Stein EA, et al: Comparisonof the efficacy and safety of rosuvastatin versusatorvastatin, simvastatin, and pravastatin across doses(STELLAR* Trial). Am J Cardiol 2003; 92:152-160.

4. Cannon CP, Braunwald E, McCabe CH, et al: Intensiveversus moderate lipid lowering with statins after acutecoronary syndromes. N Engl J Med 2004; 350:1495-1504.

5. Heart Protection Study Collaborative Group: MRC/BHFHeart Protection Study of cholesterol lowering withsimvastatin in 20,536 high-risk individuals: A randomisedplacebo controlled trial. Lancet 2002; 360:7-22.

6. ALLHAT Officers and Coordinators for the ALLHAT Col-laborative Research Group. The Antihypertensive andLipid-Lowering Treatment to Prevent Heart Attack Trial:Major outcomes in moderately hypercholesterolemic,hypertensive patients randomised to pravastatin vs usualcare: The Antihypertensive and Lipid-Lowering Treat-ment to Prevent Heart Attack Trial (ALLHAT-LLT). JAMA2002; 288:2998-3007.

7. Shepherd J, Blauw GJ, Murphy MB, et al: Pravastatinin elderly individuals at risk of vascular disease(PROSPER): A randomised controlled trial. Lancet 2002;360:1623-1630.

8. Grundy SM, Cleeman JI, Merz CN, et al: Implications ofrecent clinical trials for the National Cholesterol Educa-tion Program Adult Treatment Panel III guidelines. Cir-culation 2004; 110:227-239.

9. Haffner SM, Lehto S, Ronnemaa T, Pyorala K, LaaksoM: Mortality from coronary heart disease in subjects withtype 2 diabetes and in nondiabetic subjects with andwithout prior myocardial infarction. N Engl J Med 1998;339:229-234.

10. Lilja JJ, Kivisto KT, Neuvonen PJ: Grapefruit juice in-creases serum concentrations of atorvastatin and hasno effect on pravastatin. Clin Pharmacol Ther 1999; 66:118-127.

11. Neuvonen PJ, Jalava KM: Itraconazole drastically in-creases plasma concentrations of lovastatin andlovastatin acid. Clin Pharmacol Ther 1996; 60:54-61.

12. Kantola T, Kivisto KT, Neuvonen PJ: Erythromycin andverapamil considerably increase serum simvastatin andsimvastatin acid concentrations. Clin Pharmacol Ther1998; 64:177-182.

13. Davidson MH, Ose L, Frohlich J, et al: Differential ef-fects of simvastatin and atorvastatin on high-density lipo-protein cholesterol and apolipoprotein A-I are consis-tent across hypercholesterolemic patient subgroups. ClinCardiol 2003; 26:509-514.

14. Wierzbicki AS, Mikhailidis DP: Dose-response effectsof atorvastatin and simvastatin on high-density lipopro-tein cholesterol in hypercholesterolaemic patients: Areview of five comparative studies. Int J Cardiol 2002;84:53-57.

15. Sever PS, Dahlof B, Poulter NR, et al: Prevention ofcoronary and stroke events with atorvastatin in hyper-tensive patients who have average or lower-than-aver-age cholesterol concentrations, in the Anglo-Scandina-vian Cardiac Outcomes Trial-Lipid Lowering Arm(ASCOT-LLA): A multicentre randomised controlled trial.Lancet 2003; 361:1149-1158.

16. Ballantyne CM, Houri J, Notarbartolo A,et al: Effect ofezetimibe coadministered with atorvastatin in 628 pa-tients with primary hypercholesterolemia: A prospective,randomized, double-blind trial. Circulation 2003; 107:2409-2415.